Registration Opens for SMi's 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference
SMi Reports: The 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) will take place as a virtual conference
By: SMi Group
Highly Potent Active Pharmaceutical Ingredients (HPAPIs) play an increasing central role in the fight against many diseases. There is an increasing need to protect workers who handle HPAPIs along the life cycle of the drug product manufacturing, from synthesis of the pharmaceutical active ingredient to distribution of the finished medicinal product.
This year's event will focus on 4 key themes: best practices for toxicological assessment, innovations in containment and facility design, advances in the use of robotics and automation in manufacturing processes, and environmental considerations.
Interested parties should register at http://www.highlypotentapi.com/
The conference is chaired by Justin Mason-Home, Director, HPAPI Project Services Limited and sponsored by Catalent Pharma Solutions.
Key Speakers for HPAPi include:
Key Reasons to Attend HPAPi:
Proudly sponsored by: Catalent Pharma Solutions
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or firstname.lastname@example.org
SMi's 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi)
10 - 11 May 2021
Virtual Conference: Online Access Only